Learn how to be a restaurateur and other things to do in the San Gabriel Valley and Whittier – The Pasadena Star-News

Chef Ricardo Diaz will host a discussion about becoming restaurateur 6:30 p.m. Thursday, Feb. 27 at the Whittwood Branch Library in Whittier.

Diaz is the owner of three Whittier businesses: Colonia Publica, Bizarra Capital and Poet Gardens.

Diazs restaurant Colonia Publica was rated as one of the top 100 restaurants in the Los Angeles area by the late Jonathan Gold. Its a beer and wine bar that serves modern cantina-style plates.

Bizarra Capital is a Mexican eatery with tacos, small plates and is seafood forward. His newest restaurant and brewery is Poet Gardens, which opened recently.

He will discuss becoming a chef and restaurateur, new food concepts and how he hand picks wine. Lastly, hell talk about his newest project: Poet Gardens dining hall, a craft brewery in Uptown Whittier.

I Have Never Forgotten You: Film screening, 8 p.m. Saturday, Feb. 29 at Chabad of Pasadena. After surviving the horrors of the Holocaust, architect Simon Wiesenthal dedicated the rest of his life to hunting down Nazis who escaped prosecution after the war. This documentary details his life and his work with the American War Crimes Unit, which tracked down more than 1,000 Nazi war criminals with his help. The Chabad at Pasadena is at 1090 E. Walnut St., Pasadena.

Unscholarly Gardens: Rethinking the Gardens of China, 8:30 a.m. to 5 p.m. Saturday, Feb. 29 at the Rothenberg Hall of the Huntington in San Marino. The image of a Chinese garden that most often comes to mind is that of the white-walled, gray-tiled gardens built by scholar-officials and merchants in the city of Suzhou during the Ming dynasty. Despite its iconic status in the contemporary imagination, the Suzhou-style scholars garden is only one type among many. Exploring unscholarly spaces, such as monastic gardens, merchant gardens, medicinal gardens and market gardens, this symposium will challenge common assumptions about what makes a garden in China. $15. (An optional lunch can be pre-ordered for an additional cost.) Registration: huntington.org/calendar. The Huntington is at 1151 Oxford Road, San Marino.

Valley Con: 9 a.m. to 4 p.m. Sunday, March 1 at the Pasadena Convention Center. Valley Con is one of the largest scale model competitions and exhibitions in Southern California. Hobbyists of all skill levels and ages, along with Hollywood professionals, come to showcase their finest creations from automobiles to tanks, from Star Wars to zombies. The Pasadena Convention Center is at 300 E. Green St., Pasadena.

Golden Gates: Discussion and signing by Conor Dougherty, 7 p.m. Thursday, Feb. 27 at Vromans Bookstore in Pasadena. Punishing rents and the increasingly prohibitive cost of ownership have turned housing into a symbol of inequality and an economy gone wrong. Nowhere is this more visible than in the San Francisco Bay Area. With propulsive storytelling and ground-level reporting, New York Times journalist Conor Dougherty chronicles Americas housing crisis from its West Coast epicenter, peeling back the decades of history and taking readers inside the activist uprisings that have risen in tandem with housing costs. Vromans Bookstore is at 695 E. Colorado Blvd., Pasadena.

After/Image: Discussion and signing by Lynell George, 2 p.m. Saturday, Feb. 29. at the Allendale Branch Library. In celebration of Black History Month, the library hosts a wide-ranging discussion with award-winning Pasadena-based journalist and essayist Lynell George. Light refreshments will be served. As a former staff writer for the Los Angeles Times and L.A. Weekly, George has focused on social issues, human behavior, and identity politics as well as visual arts, music, and literature. Following the discussion, George will sign her latest book, After/Image: Los Angeles Outside the Frame. The Allendale Branch Library is at 1130 S. Marengo Ave., Pasadena.

The Impossible First: Discussion and signing by Colin OBrady, 7 p.m. Wednesday, March 4 at Vromans Bookstore in Pasadena. Prior to December 2018, no individual had ever crossed the landmass of Antarctica alone, without support and completely human powered. Yet, OBrady was determined to do just that, even if, 10 years earlier, there was doubt that hed ever walk again normally. The Impossible First reveals how anyone can reject limits, overcome immense obstacles, and discover what matters most. Vromans Bookstore is at 695 E. Colorado Blvd., Pasadena.

EDITORS NOTE: This article was edited to correct the date of the Lynell George discussion.

Continued here:
Learn how to be a restaurateur and other things to do in the San Gabriel Valley and Whittier - The Pasadena Star-News

Is Oscar-Nominated Actress Florence Pugh Starring in ‘Paddington 3’? – Showbiz Cheat Sheet

Social media has given fans an entirely new level of access to our favorite stars. Because of their very public nature, entire friendships and feuds alike are formed on sites like Twitter and Instagram. Sometimes, the internet brings out the very worst human behavior. And then, just when youre about to sign off and see what this thing called real life is all about, Paddington Bear enters the conversation.

The loveable character created by childrens author Michael Bond has become quite the celebrity in his own right. In 2014, Paddington starred in the film adaptation of the same name. Lauded by critics and audiences, Paddington spawned an even more beloved sequel. Now, thanks to his interactions with Florence Pugh, fans are giving Paddington a hard stare until we get an update on a third film.

Prior to 2019, were willing to bet only hardcore cinephiles had even heard of Pugh. Her most prominent role before then was the 2016 indie drama Lady Macbeth, where she starred opposite Star Wars Naomi Ackie. Now though? Shes well on her way to becoming a household name.

Early in 2019, Pugh played a teenage professional wrestler in the underrated comedy-drama Fighting with My Family. Then just five months later, she headlined the harrowing horror film Midsommar as a woman coping with a monumental personal loss. Finally, Pugh closed the year with the Christmas release of Greta Gerwigs Little Women.

That last film in which Pugh plays Amy March even earned the actress an Oscar nomination. Next, her star is shooting even higher, as Pugh will appear alongside Scarlett Johansson in summer 2020s Black Widow. Ironically, Pugh and Johansson were both nominated in the Best Supporting Actress category, the latter for Jojo Rabbit.

In addition to her career, Pugh has been blowing up on social media. Shes particularly active on Instagram, where she posted stories of her quest to make marmalade. For those who dont know, Paddingtons love for the orange-flavored jam is one of his most famous characteristics. So, of course, he tagged Pugh in a tweet about making marmalade.

This led to an exchange in which Pugh and Paddington plan to get together to make marmalade sandwiches. The dish is Paddingtons favorite, and so he enthusiastically leaps at the chance to chow down on some marmalade with the Oscar-nominated star.

The exchange was likely nothing more than a sweet indulgence for both Pugh and the Paddington marketing department. However, the internet runs with every bit of information it gets its hands on. So now the world is eager to discover if Pugh and Paddingtons newfound friendship means the actress is signed on for Paddington 3.

To be fair, we still dont even know the status of Paddington 3. Producer David Heyman confirmed in 2017 that a third film was in development. But the second film while similarly praised by critics made about $55 million less at the worldwide box office. This drop-off and the likelihood director Paul King wouldnt return for the third film might have caused the filmmakers to take their time, at the very least.

If Paddington 3 is coming together soon, Pugh would be a great fit. The first two films featured Nicole Kidman and Hugh Grant, respectively, as their larger-than-life villains. So we dont think Pugh is quite ready to take on that mantle. But Paddington 3 could tap into the sweetness and earnestness she brought to Little Women. If she is cast, just imagine how many marmalade sandwiches she and Paddington could make in between takes.

See original here:
Is Oscar-Nominated Actress Florence Pugh Starring in 'Paddington 3'? - Showbiz Cheat Sheet

Cutting through the AI, ML hype – Security Systems News

YARMOUTH, MaineFuture possibilities for Artificial Intelligence (AI) and Machine Learning (ML) are endless and stretch as far as the imagination can go, and continue to be hot topics of discussion among security professionals. While its smart to glimpse into the future, the security industry has to make living in reality a top priority, especially when meaning and current use cases for AI and ML tend to come with an air of confusion.

Defining AI and ML

According to Stuart Tucker, vice president, Enterprise Solutions, AMAG Technology, AI is any process where a machine or computer is programmed to think and/or act like a person whereas machine learning is where a system is capable of looking at past events and changes its behavior based on what it learned from the results.

Taking a historical view point, Jim Shaw, Crystal Groups executive vice president of engineering, defined AI as using a machine/computer to simulate a capability or emulate a biological process associated with human thought. Shaw believes that is what John McCarthy, a mathematics professor, was contemplating in 1956 at Dartmouth College when he coined the term. However, Shaw admitted that his definition of AI is less ambitious and more simplified. I think AI, as it is more commonly used today, is the compute capability to quickly sort through large amounts of data and to look for specific patterns, using algorithms designed to compare and contrast differences.

As for ML, Shaw thinks it is a subset of AI in which an algorithm is provided feedback, assessing how well the algorithm worked on a data set by determining if the right answer was achieved.

This feedback loop modifies the parameters of the algorithm so the system changes how it identifies the next pattern, explained Shaw. Technically, it changes the weighting factors of the neural network layers to improve the accuracy of the last answer. Bottom line, the feedback/correction loop is the learning part of ML.

Adopting a standard industry definition for AL and ML would be a huge step in clarifying and teaching correct meanings across the industry so that all security professionals are on the same page, so to speak. There certainly needs to be a common lexicon, which implies common understanding of these terms, said Shaw.

Tucker looks at a standard definition in terms of clarifying what a system does to end users. If you really dig down deeply, even self-learning systems are based on algorithms and programming at some level which they use to train behavior, he explained. When you look at it from a very granular level, it can get confusing as to what is really deserving of being called AI/ML versus programmed behavior in some cases.

Theres no doubt that these two concepts are difficult and adding to the confusion is other vocabulary wordsneural networks, quantum computing, cryptology, etc.that seem to play into AI and ML, in addition to misinformation, further convoluting meanings and conceptions. Perhaps for the sake of argument and for this article, we can at least all agree that AI is the process and ML is the capability of the process.

Actual trends and real use cases

The security industry is currently witnessing the use of AI and ML to quickly consume, process and analyze data to predict possible risks. AI and ML is used to look for anomalies and elevated risk.

People tend to be creatures of habit, Tucker said. When a person starts doing things that are out of the ordinary for them, it could point to an elevated risk and is at least worth noticing.

Focusing specifically on human behavior through the lens of AI and paying attention to physical human behavior can provide the needed information to make relevant security decisions, such as helping your staff make decisions about an identitys access to physical and logical assets, said Tucker. Should they be granted access to a data center or the C-Suite? Do I allow them to log in at a location when they have not badged into the building?

Also trending with AI and ML is more compute being required farther away from the data center core, while at the same time, network speeds are increasing.

Network interface speeds are increasing from 10GbE to 200GbE, indicating the amount of data is growing significantly, Shaw said. As IoT and 5G continue to come into play, we can expect the number of devices used for security to exponentially increase, making it more critical to push the right data and a lot of it.

Shaw also said that we are currently seeing AI used for retinal scans, facial recognition and finger printing in high-risk places such as court rooms, airports, train stations and large sporting arenas.

I think AI is a great way for us to sort and sift through large amounts of data to look for key pieces of information that are, frankly, boring and mundane tasks for the average personand in many cases, beyond what humans are even capable of, Shaw said.

The security industry is currently seeing and participating in the infancy of AI and ML or as Tucker puts it, just starting to scratch the surface, however, as this technology matures, we will be able to actually pre-detect and prevent issues based on recognized patterns of bad behaviors and the learned outcomes that have occurred in the past, he concluded.

See the article here:
Cutting through the AI, ML hype - Security Systems News

Shudda, Cudda, Wudda, If Only – Thrive Global

Does it, did it take you a long time to cut through the bullsh*t of life to get to your real truth? Are you even there yet? Do you know what that looks like, feels like for you?

I dont believe that many of us have NOT given any thought to our lives and where it is that were really going. After all, The Walking Dead tv series had to have come from something!!!???

We start out in life with all kinds of confusing messages, and an unclear idea of what it means to be us. if we did know, perhaps ideas were put into our minds by others and we hadnt given it any further consideration.

How we lead our life now is based upon many different configurations and sequences that weve experienced thus far. Are they the right ones for us? Did we choose the path that was best suited for us?

Experience and an understanding of human behavior tells me that were not there yet. We need to think through, pivot, then action something other than whats occurring in one or more areas of our lives. Thats not easy, as we first need to identify what that is.

The truth that we believe to be true, the truths we tell ourselves, and more importantly the truths that translate into our actions, well theres a disconnect for a lot of us.

Ego plays a heavy hand in this. Our truth is misguided when our ego rears its ugly head. Why? I believe that we get really confused with what were supposed to be doing, and what society tells us we need to be doing, and then, what it is that we know to be best for us.

Weve been so conditioned since youth that it may be that we dont have the ideas nor the words to articulate what it is in fact that we want. We may have a feeling about something. Typically, a feeling that just doesnt sit well with us. Were not sure why, and yet we do know that it feels lousy.

If we cant articulate what it is that we need or want, its difficult to then ask for help, and there lies the struggle. If in fact we did know, often we keep quiet as we feel we may be judged unfairly.

Our brains work overtime talking us out of a lot of things. A. Lot. Of. Things. Not to mention the constant limiting beliefs that we have about ourselves, as we say:No, I cant do that.Our brains still function as if its protecting us from dinosaurs. Our survival instincts are something entirely different now. Maybe even harder?!

The decades go by but were still of the mindset of old school thinking. Technology hasnt changed the way we think about working. Its certainly made it easier, and yet were still functioning in our own confinement and routine-like structure that either we or others have created for us.

The misuse of leadership and the fact that we even need to talk about how to become better leaders is upsetting. The fact that we need to discuss being kind human beings to one another is unsettling. The fact that we dont truly know ourselves authentically is sad. Could it be because we havent taken the time to better understand ourselves, and in turn we take it out on others?

It takes awfully strong humans to be able to manifest what it is that one knows to be true and then, action it.

The shudda, cudda, wudda in our lives happens when were ready. Truly ready to say; PAUSE. I need. No. I must know me. I must be me. I must lead with my truth and not fear that there will be horrible consequences.

Given what Ive said, I am optimistic that we will take the time to create space for ourselves and trust that we can and will lead more thoughtful, caring lives. Because, at the end of the day; guess what, there will be for every single one of us.

Read the original:
Shudda, Cudda, Wudda, If Only - Thrive Global

1st Watch Global Aims to Help Businesses Build a Better Crisis Preparedness and Recovery Plan – Yahoo Finance

WILMINGTON, Del., Feb. 26, 2020 (GLOBE NEWSWIRE) -- 1st Watch Global, a new consulting firm specializing in addressing and mitigating security risks, has officially launched. 1st Watch Global offers a comprehensive and fully customized approach to helping companies and organizations with all aspects of preparedness and recovery. These services include risk and threat assessments, active assailant response, Work Force Resiliency training and business continuity and recovery in the aftermath of a serious incident.

Its team of retired FBI agents, intelligence and national security specialists and law enforcement officers works with organizations to find their unique risk factors and then create a specialized plan to effectively address those factors and mitigate risk.

The Advisory Group of 1st Watch Globalwith a combined 100+ years of experiencecomprises:

Raymond HolcombPresident and Managing DirectorMr. Holcomb is a retired FBI special agent, a strategic planner with the National Counterterrorism Center and a homeland security advisor. In 2001, he oversaw the creation of the FBIs Fly Away/Rapid Deployment Team, which provided rapid deployment counterterrorism capability, responding to events domestically and worldwide. He served as Homeland Security Advisor for the state of Delaware for four years.

Michael HowardChief Operating OfficerMr. Howard is a retired FBI special agent who possesses extensive senior-level leadership, investigative, operational, training, crisis and special event management experience in law enforcement at local, state, and federal levels. Using his expertise, he works to match 1st Watch Global clients with the most effective team to meet their unique needs and requirements.

Dave GilliganExecutive Vice President and Director of OperationsMr. Gilligan has spent more than 45 years in the insurance and reinsurance industry, representing many large national and international clients. His depth of knowledge and understanding allows 1st Watch Global to provide its clients with an unprecedented level of support in all aspects of their security needs.

Andrew BinnsChief Strategy Officer Mr. Binns experience in strategic marketing has made him an influential presence in marketing across a number of industries with international scope. Most recently, he served as director of multi award-winning advertising agency, Havas. His specialization in behavior change frameworks has led to numerous individual awards and speaking opportunities. He is a well-regarded marketer who uses understanding of human behavior to create impactful work.

In addition to the extensive experience and knowledge of the 1st Watch Global Advisory Group, the firm also employs a broad range of senior advisors with a wealth of security experience who can provide crucial insight to create comprehensive risk assessments for each of 1st Watch Globals clients.

At its core, 1st Watch Global is committed to empowering institutions and organizations in providing the safest possible environment for their people, said Mr. Holcomb. This passion guides every decision we make and every action we take. Our unparalleled expertise, knowledge and experience are the tools we rely on to ensure we can make a difference in the lives of those we serve.

For more information, visit https://www.1stwatchglobal.com/

About 1st Watch Global1st Watch Global, a consulting firm comprised of retired FBI agents, intelligence and national security specialists and law enforcement officers works tirelessly to help organizations ensure the safety of their people by mitigating factors that could lead to a serious crisis event. With more than a century of experience, the team at 1st Watch Global partners with its clients to address unique risk factors and create a tailored approach to address those risks. To learn more and schedule a consult, visit https://www.1stwatchglobal.com/.

Renee Cree610-228-0404renee.cree@buchananpr.com

View post:
1st Watch Global Aims to Help Businesses Build a Better Crisis Preparedness and Recovery Plan - Yahoo Finance

Let’s hear it for the skaters | Local – Crow River Media

If you're a fan of big hair, spandex, mullets and leg warmers, you're in for a flash to the past. "Back to the '80s" is the theme of the 40th annual ice show.

Sponsored by the Hutchinson Figure Skating Association and Hutchinson Parks, Recreation and Community Education, shows are 1 p.m. and 7 p.m. Saturday and 2 p.m. Sunday at Burich Arena.

A total of 104 skaters from tots to Freestyle 4 or higher will showcase their skills to popular '80s hits such as "Jesse's Girl," "Let's Hear It For The Boy," "Girls Just Wanna Have Fun" and "Holding Out For a Hero."

The audience is in for a treat when guest skaters Jaden Schwab, 17, and Estelle Schwab, 12, take the ice. They are the children of MiShaun Schmidt, an alumni of the Hutchinson Figure Skating program. The sister-and-brother duo skate with the St. Paul Figure Skating Club. They have competed nationally and internationally. Among their honors is winning the bronze medal in the Novice and Junior Challenge in Salt Lake City, and they also qualified for the 2020 U.S pair final at the novice level and are part of the U.S. Figure Skating 2020 National Developmental Team.

Back by popular demand is the dad/daughter skate. A group of 26 family units are performing to the song "Sweet Child of Mine."

While the skating takes center stage, recognition of milestones is important, too. This is the final skating show for four seniors: Khiana Knuth, Katarina Anderson, Halii Beilke and Anna Farley. Also presented will be the HFSA Most Improved Skater Awards. Allison Schwartz was recognized in 2019 in the Freestyle 1, 2, 3 category and Emma Staples was honored in the Freestyle 4 and Up category.

Joining them is the recipient of the PRCE Most Improved Skater Award, which looks at improved overall skating ability, attitude and good sportsmanship. Elizabeth Becker was the 2019 honoree. Also awarded is the I.C.E. Award, which is presented to a skater who displays integrity, commitment and enthusiasm for the love of skating and the skating program. The 2019 recipient was Emma Schwartz.

Khiana Knuth has been skating since she was 8 years old.

"I wanted to be on the ice," she said. "I liked the idea from watching hockey with my dad."

Knuth has stuck with it for nine years. The reason: It's calming.

"It relieves stress," she said. "It lets me blow off steam."

Knuth encourages others to consider skating as a hobby.

"It can be a laid back activity or you can make it highly competitive, so it's good for a variety of people," she said.

When she's not competing, Knuth enjoys spending time with her sister, Carrie, and cousin, Caydence, at private ice. Looking ahead, Knuth's college plans call for attending North Dakota State University where she plans to study psychology.

"Human behavior interests me," she said.

Knuth admits to having mixed emotions for the coming weekend.

"I'm excited and kind of sad it will be over," she said. "I'll miss having an hour a week where I can do my own thing, blow off steam and refresh."

The Hutchinson High School senior has been skating for 13 years, starting the sport at age 5.

"My mom was a skater and I followed in her footsteps," she said.

Beilke has stuck with it because she likes it and enjoys meeting other skaters.

"It's fun to do and a cool sport," she said.

Her favorite memories revolve around the rink where she has had fun making up moves with her friends. What she'll miss most: The shows.

"I'm sad about the last ice show," she said.

After graduation, Beilke will head to Marshall to attend Southwest Minnesota State University. She plans to study early childhood education with the goal of teaching first grade.

"The age group is cool," she said.

After this weekend's ice shows, Beilke will have more time for her other favorite activities: hanging out with friends, playing softball and photography.

Farley was introduced to skating as a 3-year-old toddler. It was a good fit because she has been skating for 14 years. She stayed with the sport as a way to make friends.

"I've built some really great friendships over the years skating," she said.

Like Knuth, Farley is feeling sad and excited about this weekend's ice shows.

"I'm going to miss being with my good friends I've known since I was little," she said.

That said, Farley admitted she was ready to move on to her next chapter. After graduating from HHS, she plans to head to the University of Minnesota Twin Cities where she will study architecture.

"I love the design appeal of it, the ability to build someone else's home," she said. "It's cool to design and build."

When she's isn't at the rink, Farley can be found at Iron Jungle Crossfit, running or hanging out with her friends. She's also enrolled at Ridgewater College.

When asked if she would recommend skating to others. Farley was quick to say "yes."

"It's a really good way to be involved in a sport and to make new friendships," she said.

It's not surprising Anderson's sport is ice skating. She is named after another skater, Katarina Witt, the German figure skater who earned two Olympic gold medals. Like Farley, Anderson has been skating since she was 3 years old.

"It's been fun for me," she said. "I feel graceful and angelic on the ice."

Anderson also said skating relieves stress.

"I don't have to worry about anything but to try and get the jump," she said.

Her future plans call for attending the University of Minnesota Duluth where she will study biology with a focus on wildlife or marine biology. She chose this career path because she loves animals and wants to help the environment.

When she isn't working on her skating skills, she can be found practicing karate and volunteering at Hutchinson Health. Anderson also plays trumpet in the high school band.

"I picked it up because it would be easy, but I was wrong," she said. "I participate in every band activity I can. I like jazz. I was in all-state this past week."

Anderson also juggles work for the city of Hutchinson and attending Ridgewater College as a PSEO student.

"I'm going to miss the every-day routine of rehearsal and hanging out with my friends," she said.

See the article here:
Let's hear it for the skaters | Local - Crow River Media

New study identifies trigger that turns dormant cancer stem cells into active ones – Yahoo Finance

A new study released today in STEM CELLS identifies, for the first time, two morphologically and functionally different types of cancer stem cells found in cervical cancer.

DURHAM, N.C., Feb. 26, 2020 /PRNewswire-PRWeb/ --A new study released today in STEM CELLS identifies, for the first time, two morphologically and functionally different types of cancer stem cells found in cervical cancer. Of the two types, one exhibits an overexpression of cPLA2, a key enzyme that triggers the transformation of dormant cancer stem cells into active ones, resulting in cervical cancer metastasis and recurrence. The information in this study could lead to new targets for treatments to halt tumor recurrence and metastatic spread. Also, it might accelerate the development of combination therapies.

The current standard of treatments for cervical cancer the second leading cause of cancer death in young women worldwide is radiotherapy and chemotherapy. However, the cancer's resistance to chemotherapy and radiation, combined with a tendency to metastasis in the lymph nodes or recur in the pelvis, leaves doctors searching for more effective treatments.

Cervical cancer stem cells (CCSCs) are considered the major culprit behind the cancer's ability to overcome these treatments. At the same time, a majority of cancer stem-like cells or tumor-initiating cells remain dormant. It takes a change in their microenvironment to spur them to metastasize.

"The mechanisms responsible for this must be identified to design more suitable therapies for the different subpopulations of cancer stem cells (CSCs) in various tissue-specific cancers," said Hua Guo, Ph.D., who headed up the investigation along with Yuchao He, Ph.D. The two are colleagues at Tianjin Medical University Cancer Institute and Hospital. Researchers at Tianjin University of Traditional Chinese Medicine and at the Center for Translational Cancer Research, Peking University First Hospital, also participated in the study.

Although several cell surface antigens have been identified in CCSCs, these markers vary among tumors because of CSC heterogeneity. However, whether these markers specifically distinguish CCSCs with different functions is unclear. The study published in STEM CELLS sought to resolve this question. And in fact, its findings demonstrate that CCSCs exist in two biologically distinct phenotypes, characterized by different levels of cPLA2 expression.

"Our study showed for the first time that overexpression of cPLA2 results in a phenotype associated with mesenchymal traits, including increased invasive and migration abilities. On the other hand, CCSCs with cPLA2 downregulation show dormant epithelial characteristics," said Dr. Guo. "In addition, cPLA2 regulates the reversible transition between mesenchymal and epithelial CCSC states through PKC, an atypical protein that governs cancer cell state changes."

Dr. He added, "Now that we know cPLA2 triggers this transformation, we believe that cPLA2 might be an attractive therapeutic target for eradicating different states of CCSCs to eliminate tumors more effectively."

"The novel study by Dr. Guo and team is of very high importance in understanding the transition between dormant cancer stem cells, which evade chemotherapy and radiation treatments, and actively dividing cells which can be better targeted, said Dr. Jan Nolta, Editor-in-Chief of STEM CELLS. "I applaud the group for this important discovery which will help researchers develop better treatments for cervical cancer."

###

The full article, "cPLA2 reversibly regulate different subsets of cancer stem cells transformation in cervical cancer," can be accessed at https://stemcellsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/stem.3157.

Figure Caption: This study revealed that there are two morphologically and functionally distinct cancer stem cell populations regulated by cPLA2 in cervical cancer. cPLA2 might be a unique marker to identify different cancer stem cell populations and trigger quiescent epithelial cancer stem cells transform to invasive mesenchymal states. Overexpression of cPLA2 resulted in a CD44+CD24- phenotype with mesenchymal traits, whereas cervical cancer stem cells (CCSCs) with cPLA2 downregulation expressed CD133 and showed epithelial characteristics. cPLA2, as a key role to reversely regulate CCSCs states and EMT, might provide innovative therapeutic strategies intended to halt tumor recurrence and metastasis.

Story continues

About the Journal: STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. The journal covers all aspects of stem cells: embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; cancer stem cells; the stem cell niche; stem cell epigenetics, genomics and proteomics; and translational and clinical research. STEM CELLS is co-published by AlphaMed Press and Wiley.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes three internationally renowned peer-reviewed journals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. STEM CELLS (http://www.StemCells.com) is the world's first journal devoted to this fast paced field of research. THE ONCOLOGIST (http://www.TheOncologist.com) is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. STEM CELLS TRANSLATIONAL MEDICINE (http://www.StemCellsTM.com) is dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.

About Wiley: Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical and scholarly journals, combined with our digital learning, assessment and certification solutions, help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.

SOURCE AlphaMed Press

Read the original:
New study identifies trigger that turns dormant cancer stem cells into active ones - Yahoo Finance

On the Road to 3-D Printed Organs – The Scientist

For years, scientists have predicted that 3-D printingwhich has been used it to make toys, homes, scientific tools and even a plastic bunny that contained a DNA code for its own replicationcould one day be harnessed to print live, human body parts to mitigate a shortage of donor organs. So far, researchers also used 3-D printing in medicine and dentistry to create dental implants, prosthetics, and models for surgeons to practice on before they make cuts on a patient. But many researchers have moved beyond printing with plastics and metalsprinting with cells that then form living human tissues.

No one has printed fully functional, transplantable human organs just yet, but scientists are getting closer, making pieces of tissue that can be used to test drugs and designing methods to overcome the challenges of recreating the bodys complex biology.

A confocal microscopy image showing 3-Dprinted stem cells differentiating into bone cells

The first 3-D printer was developed in the late 1980s. It could print small objects designed using computer-aided design (CAD) software. A design would be virtually sliced into layers only three-thousandths of a millimeter thick. Then, the printer would piece that design into the complete product.

There were two main strategies a printer might use to lay down the pattern: it could extrude a paste through a very fine tip, printing the design starting with the bottom layer and working upward with each layer being supported by the previous layers. Alternatively, it could start with a container filled with resin and use a pointed laser to solidify portions of that resin to create a solid object from the top down, which would be lifted and removed from the surrounding resin.

When it comes to printing cells and biomaterials to make replicas of body parts and organs, these same two strategies apply, but the ability to work with biological materials in this way has required input from cell biologists, engineers, developmental biologists, materials scientists, and others.

So far, scientists have printed mini organoids and microfluidics models of tissues, also known as organs on chips. Both have yielded practical and theoretical insights into the function of the human body. Some of these models are used by pharmaceutical companies to test drugs before moving on to animal studies and eventually clinical trials. One group, for example, printed cardiac cells on a chip and connected it to a bioreactor before using it to test the cardiac toxicity of a well-known cancer drug, doxorubicin. The team showed that the cells beating rate decreased dramatically after exposure to the drug.

However, scientists have yet to construct organs that truly replicate the myriad structural characteristics and functions of human tissues. There are a number of companies who are attempting to do things like 3-D print ears, and researchers have already reported transplanting 3-D printed ears onto children who had birth defects that left their ears underdeveloped, notes Robby Bowles, a bioengineer at the University of Utah. The ear transplants are, he says, kind of the first proof of concept of 3-D printing for medicine.

THE SCIENTIST STAFF

Bowles adds that researchers are still a ways away from printing more-complex tissues and organs that can be transplanted into living organisms. But, for many scientists, thats precisely the goal. As of February 2020, more than 112,000 people in the US are waiting for an organ transplant, according to the United Network for Organ Sharing. About 20 of them die each day.

For many years, biological engineers have tried to build 3-D scaffolds that they could seed with stem cells that would eventually differentiate and grow into the shapes of organs, but to a large extent those techniques dont allow you to introduce kind of the organization of gradients and the patterning that is in the tissue, says Bowles. There is no control over where the cells go in that tissue. By contrast, 3-D printing enables researchers with to very precisely direct the placement of cellsa feat that could lead to better control over organ development.

Ideally, 3-D printed organs would be built from cells that a patients immune system could recognize as its own, to avoid immune rejection and the need for patients to take immunosuppressive drugs. Such organs could potentially be built from patient-specific induced pluripotent stem cells, but one challenge is getting the cells to differentiate into the subtype of mature cell thats needed to build a particular organ. The difficulty is kind of coming together and producing complex patternings of cells and biomaterials together to produce different functions of the different tissues and organs, says Bowles.

To imitate the patterns seen in vivo, scientists print cells into hydrogels or other environments with molecular signals and gradients designed to coax the cells into organizing themselves into lifelike organs. Scientists can use 3-D printing to build these hydrogels as well. With other techniques, the patterns achieved have typically been two-dimensional, Eben Alsberg, a bioengineer at the University of Illinois, tells The Scientist in an email. Three-dimensional bioprinting permits much more control over signal presentation in 3D.

So far, researchers have created patches of tissue that mimic portions of certain organs but havent managed to replicate the complexity or cell density of a full organ. But its possible that in some patients, even a patch would be an effective treatment. At the end of 2016, a company called Organovo announced the start of a program to develop 3-D printed liver tissue for human transplants after a study showed that transplanted patches of 3-D printed liver cells successfully engrafted in a mouse model of a genetic liver disease and boosted several biomarkers that suggested an improvement in liver function.

Only in the past few years have researchers started to make headway with one of the biggest challenges in printing 3-D organs: creating vasculature. After the patches were engrafted into the mouses liver in the Organovo study, blood was delivered to it by the surrounding liver tissue, but an entire organ would need to come prepared for blood flow.

For any cells to stay alive, [the organ] needs that blood supply, so it cant just be this huge chunk of tissue, says Courtney Gegg, a senior director of tissue engineering at Prellis Biologics, which makes and sells scaffolds to support 3-D printed tissue. Thats been recognized as one of the key issues.

Mark Skylar-Scott, a bioengineer at the Wyss Institute, says that the problem has held back tissue engineering for decades. But in 2018, Sbastian Uzel, Skylar-Scott, and a team at the Wyss Institute managed to 3-D print a tiny, beating heart ventricle complete with blood vessels. A few days after printing the tissue, Uzel says he came into the lab to find a piece of twitching tissue, which was both very terrifying and exciting.

For any cells to stay alive, [the organ] needs that blood supply, so it cant just be this huge chunk of tissue.

Courtney Gegg, Prellis Biologics

Instead of printing the veins in layers, the team used embedded printinga technique in which, instead of building from the bottom of a slide upwards, material is extruded directly into a bath, or matrix. This strategy, which allows the researchers to print free form in 3-D, says Skylar-Scott, rather having to print each layer one on top of the other to support the structure, is a more efficient way to print a vascular tree. The matrix in this case was the cellular material that made up the heart ventricle. A gelatin-like ink pushed these cells gently out of the way to create a network of channels. Once printing was finished, the combination was warmed up. This heat caused the cellular matrix to solidify, but the gelatin to liquify so it could then be rinsed out, leaving space for blood to flow through.

But that doesnt mean the problem is completely solved. The Wyss Institute teams ventricle had blood vessels, but not nearly as many as a full-sized heart. Gegg points out that to truly imitate human biology, an individual cell will have to be within 200 microns of your nearest blood supply. . . . Everything has to be very, very close. Thats far more intricate than what researchers have printed so far.

Due to hurdles with adding vasculature and many other challenges that still face 3-Dprinted tissues, laboratory-built organs wont be available for transplant anytime soon. In the meantime, 3-D printing portions of tissue is helping accelerate both basic and clinical research about the human body.

Emma Yasinski is a Florida-based freelance reporter. Follow her on Twitter@EmmaYas24.

Read the original post:
On the Road to 3-D Printed Organs - The Scientist

Breast cancer cells hibernate in the lung before forming secondary tumors – News-Medical.net

Feb 24 2020

Healthy lung cells support the survival of breast cancer cells, allowing them to hibernate in the lung before forming secondary tumors, according to new research from the Crick. The findings could help the development of new treatments that interfere with this behavior, reducing the number of secondary cancers.

Image showing mouse breast cancer cells (orange) within lung tissue (light pink), connected with protein fibres (purple).

The study, published in Nature Cell Biology, used a mouse model to show that, after cancer cells from a breast tumor arrive in the lungs, a signal sent out from the lung cells causes cancer cells to change shape and grow protrusions that latch onto the lung tissue. The lung cells then protect them within the lung tissue.

By using a treatment that interferes with the growth of these protrusions on the breast cancer cells, the researchers found that mice who received the treatment grew fewer secondary tumors than the control mice.

The researchers then analyzed the genes that are turned on in the hibernating cells. This enabled them to find a key gene, sFRP2, that regulates the formation of cell protrusions and the survival of breast cancer cells in the lung.

Cancer can survive, hibernating in different parts of the body, for many years. By showing how the microenvironment around the cancer cell can support its survival, in our case how the lung cells help the breast cancer cells, opens the door to potential new treatments which target this relationship.

Erik Sahai, co-lead author and group leader of the Cricks Tumour Cell Biology Laboratory

The cancer cells were tested over the course of up to four weeks, during which they remained inactive. In comparison, other cell types continued to remain active, showing that the hibernation of these cells is due to a special relationship they have with the lung environment around them.

The mechanism behind how cancer cells survive in tissues they have traveled to is not yet well understood. But with many cancers spreading around the body and consequently many patients suffering from relapses, a deeper understanding of the process is vital and something well continue to explore, says Marco Montagner, co-lead author and former postdoc in the Cricks Tumour Cell Biology Laboratory, who is now based at the University of Padua.

Around 55,000 people in the UK are diagnosed with breast cancer each year. This cancer can spread through the blood or lymphatic system to another part of the body, commonly the lungs, liver, brain or bones. Where breast cancer spreads to the lungs, there can be a long time between the cells arriving in the lungs and the formation of a secondary tumor. This gap is one factor that explains why people may relapse a long time after the initial disease.

The researchers are continuing to explore the relationship between cancer and non-cancerous cells in a secondary location in the body. At the Crick, researchers are now studying what happens when cells from colorectal cancer and melanomas form secondary tumors in the liver. While at the University of Padua, studies are ongoing into the genes which are over-expressed in hibernating breast cancer cells.

Source:

Journal reference:

Montagner, M., et al. (2020) Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination. Nature Cell Biology. doi.org/10.1038/s41556-020-0474-3.

View original post here:
Breast cancer cells hibernate in the lung before forming secondary tumors - News-Medical.net

Bit Bio Secures Distribution Agreement with Abcam to Democratize Access to Human Cells for Global Life Science Research – BioSpace

CAMBRIDGE, England, Feb. 25, 2020 /PRNewswire/ --Bit Bio announces agreement with Abcam, a global innovator in life science reagents and tools, to make Bit Bio's iPSC derived functional human cells widely available to the global life science community. Over the course of the next two years this new partnership will provide an increasing range of highly defined, scalable and consistent human cells for research and high-throughput screening applications. The first product available are brain cells (ioNEURONS/glutTM, glutamatergic neurons) serving the neuroscience community.

Access to human cells is a significant bottleneck in the field of medical research and drug development. Human cells differ from animal models, and therefore research using animal models often does not translate into clinical applications.

Bit Bio is commercializing opti-oxTM, a precise reprogramming proprietary technology platform that enables uniquely efficient and consistent production of human cells for use in research, drug discovery, and cell therapy.

"Bit Bio's goal is to develop a scalable technology platform capable of producing consistent batches of every human cell type," said Bit Bio CEO Mark Kotter, a neurosurgeon at Cambridge University, and stem cell biologist. "This agreement will accelerate our mission of putting highly defined human cells in the hands of the researchers who need them to pursue their life-saving work."

"Supporting enhanced access to complementary technologies that have the potential to improve and accelerate research is part of our growth strategy," said John Baker, Senior Vice President Product Portfolio and Innovation at Abcam. "Our industry expertise, and co-location in major biotechnology hubs throughout the world, enables our partners to rapidly put their innovations into the hands of the global research community, helping advance the understanding of biology and cause of disease to enable new treatments and improved health outcomes."

Bit Bio's breakthrough technology has been successfully employed to reprogram stem cells into functional neurons on a scalable and consistent basis. The proprietary approach ensures batch to batch reproducibility and unprecedented purity compared to current technologies and yields fully differentiated neurons within days. The protocol is also universally applicable, from small-scale laboratory research projects to high throughput screens in pharmaceutical R&D laboratories.

Bit Bio's human-induced glutamatergic neurons are a highly defined and consistent human model for the study of neurological physiology and disease, including neurodegeneration, and are available from the Abcam website.

"At Bit Bio we believe that world-wide access to our iPSC derived cells will drive human translational experiments and ultimately help to fuel the next generation of medicine," said Bit Bio Chief Business Officer Paul Morrill. "Abcam's reputation as a disruptive innovator in the field of biological reagents and dedicated global commercialization infrastructure make them the ideal partner. In line with our core value of democratizing access to human cells for research and drug development, our ioNEURONS/glut are offered at a highly competitive price point."

About Bit Bio

Bit Bio, the cell coding company, is based in Cambridge, UK. Bit Bio's team includes world leaders in stem cell biology, cellular reprogramming and cell therapy who are harnessing the power of synthetic biology to tackle the problem of inconsistency in the production of human cells. Bit Bio is developing opti-oxTM, a proprietary technology platform capable of producing any human cell for research, drug discovery and cell therapy.

We areintroducing ioNEURONS/glutTM,human-induced glutamatergic neuronscells, providing a high-quality human model for research, drug development and high-throughput screening.ioNEURONS/glut cells have been reprogrammed from human induced pluripotent stem cells (hiPSC) using a precise reprogramming technology.

To find out more, please visit http://www.bit.bio

Bit Bio press contact:Dr Farah Patell-Socha, press@bit.bio

About AbcamAs a global life sciences company, Abcam identifies, develops, and distributes high-quality biological reagents and tools that are crucial to research, drug discovery and diagnostics. Working across the industry, the Company supports life scientists to achieve their mission, faster. Abcam partners with life science organisations to co-create novel binders for use in drug discovery,in vitrodiagnostics and therapeutics, driven by the Company's proprietary discovery platforms and world-leading, antibody expertise.

By constantly innovating its binders and assays, Abcam is helping advance the global understanding of biology and causes of disease, which enables new treatments and improved health. The Company's pioneering data-sharing approach gives scientists increased confidence in their results by providing validation, user comments and peer-reviewed citations for its 110,000 products. With eleven sites globally, many of Abcam's 1,100 strong team are located in the world's leading life science research hubs, complementing a global network of services and support.

To find out more, please visitwww.abcam.comandwww.abcamplc.com.

Abcam press contact:Dr Lynne Trowbridge, lynne.trowbridge@abcam.com

View original content:http://www.prnewswire.com/news-releases/bit-bio-secures-distribution-agreement-with-abcam-to-democratize-access-to-human-cells-for-global-life-science-research-301010337.html

SOURCE Bit Bio

See more here:
Bit Bio Secures Distribution Agreement with Abcam to Democratize Access to Human Cells for Global Life Science Research - BioSpace